SummaryObjectiveTo explore the knowledge, attitude, perception and practice towards
antimicrobial use in upper respiratory tract infections in patients visiting
healthcare settings in Qatar.DesignSystematic review was performed using a predetermined protocol and in
accordance with standardized reporting guidelines. MEDLINE, PubMed, EMBASE,
Global Health and PsycINFO were searched for relevant published studies
using relevant MESH terms and keywords.SettingAll healthcare settings in Qatar including both inpatient and ambulatory
care.ParticipantsAll published articles exploring the antimicrobial use in upper respiratory
tract infections at any health setting in Qatar were considered for
inclusion in the study. No age, gender or population were excluded.Main Outcome Measure(s)The outcome of interest was antimicrobial use in upper respiratory tract
infections in Qatar. We included all related studies to explore the
knowledge, attitude, perception and practice for patients visiting all
health care settings.ResultsThree articles were included, one in a primary care setting, one in a
secondary care setting and one in the private sector. Overprescribing was
noted in all settings. Our findings demonstrate low expectations to receive
antibiotics, among the Qatari population, in primary care (28.1%). In fact,
the majority of patients would be satisfied with reassurance rather than
receiving antimicrobials. Many patients were satisfied with explanation from
physicians and counselling. Private sector registered high prevalence of
antimicrobial misuse for respiratory tract infections in which 85% deemed
inappropriate. This finding was also noted at a medical intensive care unit
which showed high antimicrobial use (76%) and respiratory tract infections
accounted for 57% of prescriptions.ConclusionStudies are needed to determine factors and population-based rates of
antimicrobial use in all healthcare settings. There is also a need for
interventional programs for both physicians and public on appropriate use of
antimicrobials to combat global antimicrobial resistance.